US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Genprex, Inc.

0.2057

-0.0238-10.37%

Post-market: 0.2012-0.0045-2.19%17:06 EDT

Volume:172.69M

Turnover:52.62M

Market Cap:6.88M

PE:-0.08

High:0.4045

Open:0.3083

Low:0.2041

Close:0.2295

52wk High:3.97

52wk Low:0.1400

Shares:33.47M

Float Shares:33.15M

Volume Ratio:6.26

T/O Rate:521.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5758

EPS(LYR):-5.3391

ROE:-612.30%

ROA:-207.41%

PB:4.95

PE(LYR):-0.04

Loading ...

Overview Company News Filings

Genprex Inc. Faces Potential Nasdaq Delisting Due to Non-Compliance with Stockholders' Equity Requirement

Genprex Inc. Receives Notice of Allowance for Patents on Reqorsa® Gene Therapy with PD-L1 and PD-1 Antibodies to Combat Cancers

Genprex Inc. Conducted Annual Stockholders Meeting

Genprex Q2 EPS $(0.17) Beats $(0.42) Estimate

Genprex Inc. Reports Significant Deviation from Forecast with Lower Sales and Increased Net Loss in Latest Results

BRIEF-Genprex Issues Stockholder Letter And Provides 2025 Corporate Update

Genprex Inc. Announces New Progress in Lung Cancer Clinical Trials and Outlines Key Milestones for 2025

Genprex Inc. Announces Promising Preclinical Results for Diabetes Gene Therapy GPX-002 at 2025 ADA Scientific Sessions

Genprex Announces Promising Preclinical Results for Novel Diabetes Gene Therapy Using Non-Viral Lipid Nanoparticle Delivery System at 2025 ADA Conference

Genprex Files for Resale of 15 Million Shares

MT Newswires Live

Genprex Inc. Enters $12.5 Million Share Purchase Agreement with Lincoln Park Capital

Genprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge

Genprex Inc. Announces Phase 1/2 Clinical Trial of Quaratusugene Ozeplasmid Gene Therapy for Small Cell Lung Cancer

Genprex Inc. to Participate in BIO International Convention in Boston

Genprex Inc. Announces Promising Preclinical Results for Novel Diabetes Gene Therapy at ASGCT Annual Meeting

Genprex Q1 EPS $(0.26) Beats $(0.41) Estimate

Genprex Inc expected to post a loss of 41 cents a share - Earnings Preview

BRIEF-Genprex Collaborators Report Positive Preclinical Data On The Use Of Reqorsa Gene Therapy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GNPX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNPX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNPX\",,,,,undefined,":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":0.2057,"timestamp":1757361600000,"preClose":0.2295,"halted":0,"volume":172690027,"hourTrading":{"tag":"盘后","latestPrice":0.2012,"preClose":0.2057,"latestTime":"17:06 EDT","volume":458511,"amount":93602.14120092,"timestamp":1757365602831},"delay":0,"floatShares":33145048,"shares":33466784,"eps":-2.575835,"marketStatus":"Post-Mkt","change":-0.0238,"latestTime":"09-08 17:07:45 EDT","open":0.3083,"high":0.40449,"low":0.2041,"amount":52623424.37924629,"amplitude":0.873159,"askPrice":0.2085,"askSize":100,"bidPrice":0.2,"bidSize":3261,"shortable":0,"etf":0,"ttmEps":-2.575835,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1757376000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1522296000000,"exchange":"NASDAQ","adjPreClose":0.2295,"preHourTrading":{"tag":"盘前","latestPrice":0.3097,"preClose":0.2295,"latestTime":"09:29 EDT","volume":9133120,"amount":2594693.4539392,"timestamp":1757338197903},"postHourTrading":{"tag":"盘后","latestPrice":0.2012,"preClose":0.2057,"latestTime":"17:06 EDT","volume":458511,"amount":93602.14120092,"timestamp":1757365602831},"volumeRatio":6.255843,"impliedVol":3.1839,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNPX\",,,,,undefined,":{"symbol":"GNPX","floatShares":33145048,"roa":"-207.41%","roe":"-612.30%","lyrEps":-5.339069,"volumeRatio":6.255843,"shares":33466784,"dividePrice":0,"high":0.40449,"amplitude":0.873159,"preClose":0.2295,"low":0.2041,"week52Low":0.14,"pbRate":"4.95","week52High":3.97,"institutionHeld":0,"latestPrice":0.2057,"committee":0.940494,"eps":-2.575835,"divideRate":0,"volume":172690027,"delay":0,"ttmEps":-2.575835,"open":0.3083,"prevYearClose":0.8516,"prevWeekClose":0.2295,"prevMonthClose":0.164,"prevQuarterClose":0.2279,"fiveDayClose":0.164,"twentyDayClose":0.2138,"sixtyDayClose":0.3078},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNPX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"GNPX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2025-05-12","symbol":"GNPX","fiscalQuarterEnding":"2025/03","expectedEps":-0.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.26},{"date":"2025-04-01","symbol":"GNPX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743494400000,"name":null,"time":"Pre-Market","dateTimestamp":1743480000000,"actualEps":null},{"market":"US","date":"2024-11-13","symbol":"GNPX","fiscalQuarterEnding":"2024/09","expectedEps":-1.13,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-1.23},{"market":"US","date":"2024-08-09","symbol":"GNPX","fiscalQuarterEnding":"2024/06","expectedEps":-2.3,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNPX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNPX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GNPX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GNPX","date":"2025-09-05","current":-0.296689,"percent":0.791837,"low":-21.925059,"twenty":-7.330145,"median":-2.607248,"eighty":-0.28173,"high":-0.045425,"avg":-3.667088,"sd":3.979841,"marketCap":5210778},"quantilePoints":[{"date":"2020-09-11","current":-9.229692,"twenty":-10.412096,"median":-3.057052,"eighty":-1.259201,"marketCap":136047464},{"date":"2020-09-18","current":-10.020809,"twenty":-10.390665,"median":-3.116797,"eighty":-1.261969,"marketCap":147708675},{"date":"2020-09-25","current":-8.886875,"twenty":-10.374174,"median":-3.176468,"eighty":-1.267464,"marketCap":130994272},{"date":"2020-10-02","current":-8.755022,"twenty":-10.347803,"median":-3.250657,"eighty":-1.272846,"marketCap":129050737},{"date":"2020-10-09","current":-9.888956,"twenty":-10.289788,"median":-3.278441,"eighty":-1.277321,"marketCap":145765140},{"date":"2020-10-16","current":-9.862585,"twenty":-10.337255,"median":-3.296963,"eighty":-1.282293,"marketCap":145376432},{"date":"2020-10-23","current":-8.939616,"twenty":-10.289788,"median":-3.371052,"eighty":-1.284365,"marketCap":131771686},{"date":"2020-10-30","current":-8.570429,"twenty":-10.242321,"median":-3.398836,"eighty":-1.28442,"marketCap":126329788},{"date":"2020-11-06","current":-8.280352,"twenty":-10.225919,"median":-3.482186,"eighty":-1.289392,"marketCap":122054010},{"date":"2020-11-13","current":-8.269479,"twenty":-10.212049,"median":-3.732236,"eighty":-1.298407,"marketCap":125195161},{"date":"2020-11-20","current":-8.217141,"twenty":-10.197066,"median":-3.773548,"eighty":-1.309513,"marketCap":124402787},{"date":"2020-11-27","current":-8.086295,"twenty":-10.186518,"median":-3.963765,"eighty":-1.314773,"marketCap":122421850},{"date":"2020-12-04","current":-9.133064,"twenty":-10.162046,"median":-3.982287,"eighty":-1.321372,"marketCap":138269339},{"date":"2020-12-11","current":-8.609679,"twenty":-10.132457,"median":-4.012381,"eighty":-1.330394,"marketCap":130345595},{"date":"2020-12-18","current":-9.316249,"twenty":-10.115743,"median":-4.093421,"eighty":-1.330394,"marketCap":141042650},{"date":"2020-12-24","current":-13.337475,"twenty":-10.189013,"median":-4.16751,"eighty":-1.330508,"marketCap":201921702},{"date":"2020-12-31","current":-11.801817,"twenty":-10.231773,"median":-4.195293,"eighty":-1.330963,"marketCap":178672722},{"date":"2021-01-08","current":-10.721169,"twenty":-10.363626,"median":-4.260121,"eighty":-1.352943,"marketCap":162312328},{"date":"2021-01-15","current":-10.664292,"twenty":-10.415357,"median":-4.322862,"eighty":-1.364217,"marketCap":161451255},{"date":"2021-01-22","current":-11.14774,"twenty":-10.466212,"median":-4.371255,"eighty":-1.368727,"marketCap":168770378},{"date":"2021-01-29","current":-12.711836,"twenty":-10.506027,"median":-4.45103,"eighty":-1.392404,"marketCap":192449895},{"date":"2021-02-05","current":-17.773821,"twenty":-10.66998,"median":-4.49165,"eighty":-1.470198,"marketCap":269085425},{"date":"2021-02-12","current":-20.038417,"twenty":-10.798701,"median":-4.537955,"eighty":-1.518182,"marketCap":303370115},{"date":"2021-02-19","current":-18.06602,"twenty":-10.901429,"median":-4.612044,"eighty":-1.543798,"marketCap":273509148},{"date":"2021-02-26","current":-14.750105,"twenty":-11.016925,"median":-4.704655,"eighty":-1.555884,"marketCap":223308102},{"date":"2021-03-05","current":-14.006882,"twenty":-11.130677,"median":-4.815789,"eighty":-1.555884,"marketCap":212056143},{"date":"2021-03-12","current":-15.09313,"twenty":-11.519089,"median":-4.973229,"eighty":-1.555884,"marketCap":228501313},{"date":"2021-03-19","current":-14.521421,"twenty":-11.767691,"median":-5.112145,"eighty":-1.563616,"marketCap":219845961},{"date":"2021-03-26","current":-10.877819,"twenty":-12.08051,"median":-5.236762,"eighty":-1.574568,"marketCap":195178205},{"date":"2021-04-01","current":-10.178358,"twenty":-11.956128,"median":-5.493575,"eighty":-1.578433,"marketCap":182627944},{"date":"2021-04-09","current":-10.757222,"twenty":-11.802935,"median":-6.19147,"eighty":-1.582943,"marketCap":193014367},{"date":"2021-04-16","current":-9.551256,"twenty":-11.779536,"median":-6.342191,"eighty":-1.589708,"marketCap":171375985},{"date":"2021-04-23","current":-9.358301,"twenty":-11.745645,"median":-6.443704,"eighty":-1.589708,"marketCap":167913844},{"date":"2021-04-30","current":-10.030902,"twenty":-11.728075,"median":-6.506884,"eighty":-1.600096,"marketCap":179982170},{"date":"2021-05-07","current":-9.027812,"twenty":-11.700726,"median":-6.565294,"eighty":-1.61574,"marketCap":161983953},{"date":"2021-05-14","current":-8.763841,"twenty":-11.64428,"median":-6.593258,"eighty":-1.618913,"marketCap":157247580},{"date":"2021-05-21","current":-9.389265,"twenty":-11.534135,"median":-6.635387,"eighty":-1.623652,"marketCap":177140346},{"date":"2021-05-28","current":-9.389265,"twenty":-11.418585,"median":-6.7366,"eighty":-1.628223,"marketCap":177140346},{"date":"2021-06-04","current":-9.21353,"twenty":-11.302943,"median":-6.815539,"eighty":-1.639316,"marketCap":173824885},{"date":"2021-06-11","current":-9.188425,"twenty":-11.23983,"median":-6.84555,"eighty":-1.66412,"marketCap":173351248},{"date":"2021-06-18","current":-8.510591,"twenty":-11.142052,"median":-6.949742,"eighty":-1.691797,"marketCap":160563041},{"date":"2021-06-25","current":-9.01269,"twenty":-11.113614,"median":-6.999729,"eighty":-1.69741,"marketCap":170035787},{"date":"2021-07-02","current":-8.385066,"twenty":-11.079489,"median":-7.065632,"eighty":-1.713098,"marketCap":158194854},{"date":"2021-07-09","current":-7.958281,"twenty":-11.033988,"median":-7.136233,"eighty":-1.725648,"marketCap":150143020},{"date":"2021-07-16","current":-7.280446,"twenty":-11.033988,"median":-7.21558,"eighty":-1.725648,"marketCap":137354814},{"date":"2021-07-23","current":-7.682126,"twenty":-11.00555,"median":-7.278295,"eighty":-1.747551,"marketCap":144933010},{"date":"2021-07-30","current":-7.431076,"twenty":-10.986719,"median":-7.280446,"eighty":-1.781375,"marketCap":140196637},{"date":"2021-08-06","current":-7.355761,"twenty":-10.915877,"median":-7.28958,"eighty":-1.788399,"marketCap":138775725},{"date":"2021-08-13","current":-7.098667,"twenty":-10.915877,"median":-7.28958,"eighty":-1.793889,"marketCap":131176885},{"date":"2021-08-20","current":-6.66143,"twenty":-10.891797,"median":-7.280446,"eighty":-1.802796,"marketCap":123097149},{"date":"2021-08-27","current":-7.844541,"twenty":-10.877819,"median":-7.280446,"eighty":-1.803924,"marketCap":144959963},{"date":"2021-09-03","current":-7.895981,"twenty":-10.864666,"median":-7.298278,"eighty":-1.806855,"marketCap":145910520},{"date":"2021-09-10","current":-7.510184,"twenty":-10.831628,"median":-7.306975,"eighty":-1.822549,"marketCap":138781342},{"date":"2021-09-17","current":-7.330145,"twenty":-10.798701,"median":-7.306975,"eighty":-1.826473,"marketCap":135454392},{"date":"2021-09-24","current":-7.175826,"twenty":-10.767587,"median":-7.298278,"eighty":-1.833664,"marketCap":132602721},{"date":"2021-10-01","current":-6.944348,"twenty":-10.758048,"median":-7.28958,"eighty":-1.835462,"marketCap":128325213},{"date":"2021-10-08","current":-6.352792,"twenty":-10.72838,"median":-7.280446,"eighty":-1.835462,"marketCap":117393806},{"date":"2021-10-15","current":-6.198473,"twenty":-10.698418,"median":-7.255341,"eighty":-1.848012,"marketCap":114542135},{"date":"2021-10-22","current":-5.889836,"twenty":-10.66998,"median":-7.246475,"eighty":-1.885526,"marketCap":108838792},{"date":"2021-10-29","current":-5.992715,"twenty":-10.664292,"median":-7.21558,"eighty":-1.897394,"marketCap":110739906},{"date":"2021-11-05","current":-5.581198,"twenty":-10.571434,"median":-7.175826,"eighty":-1.899493,"marketCap":103135449},{"date":"2021-11-12","current":-5.324,"twenty":-10.54822,"median":-7.149395,"eighty":-1.911083,"marketCap":98382663},{"date":"2021-11-19","current":-4.345777,"twenty":-10.506027,"median":-7.110869,"eighty":-1.9139,"marketCap":83186911},{"date":"2021-11-26","current":-3.946166,"twenty":-10.495479,"median":-7.071943,"eighty":-1.923313,"marketCap":75537540},{"date":"2021-12-03","current":-3.321772,"twenty":-10.494401,"median":-7.032575,"eighty":-1.935366,"marketCap":63585398},{"date":"2021-12-10","current":-3.671432,"twenty":-10.4772,"median":-6.999197,"eighty":-1.959512,"marketCap":70278597},{"date":"2021-12-17","current":-3.446651,"twenty":-10.466212,"median":-6.995787,"eighty":-1.993335,"marketCap":65975826},{"date":"2021-12-23","current":-3.596505,"twenty":-10.456822,"median":-6.982927,"eighty":-2.006865,"marketCap":68844340},{"date":"2021-12-31","current":-3.271821,"twenty":-10.432189,"median":-6.940675,"eighty":-2.007267,"marketCap":62629226},{"date":"2022-01-07","current":-5.544612,"twenty":-10.415963,"median":-6.937002,"eighty":-2.00787,"marketCap":106135025},{"date":"2022-01-14","current":-5.644515,"twenty":-10.412554,"median":-6.869229,"eighty":-2.011978,"marketCap":108047368},{"date":"2022-01-21","current":-4.545583,"twenty":-10.405766,"median":-6.830954,"eighty":-2.019255,"marketCap":87011597},{"date":"2022-01-28","current":-4.570559,"twenty":-10.394679,"median":-6.815749,"eighty":-2.026852,"marketCap":87489683},{"date":"2022-02-04","current":-5.494661,"twenty":-10.391334,"median":-6.786437,"eighty":-2.04254,"marketCap":105178854},{"date":"2022-02-11","current":-5.61954,"twenty":-10.384722,"median":-6.764309,"eighty":-2.057219,"marketCap":107569282},{"date":"2022-02-18","current":-5.519637,"twenty":-10.358352,"median":-6.660476,"eighty":-2.066743,"marketCap":105656939},{"date":"2022-02-25","current":-5.569588,"twenty":-10.337255,"median":-6.635549,"eighty":-2.070777,"marketCap":106613111},{"date":"2022-03-04","current":-5.344806,"twenty":-10.337255,"median":-6.597859,"eighty":-2.076582,"marketCap":102310339},{"date":"2022-03-11","current":-5.269879,"twenty":-10.298955,"median":-6.585551,"eighty":-2.109687,"marketCap":100876082},{"date":"2022-03-18","current":-6.069103,"twenty":-10.258144,"median":-6.558551,"eighty":-2.11784,"marketCap":116174825},{"date":"2022-03-25","current":-5.919248,"twenty":-10.231773,"median":-6.532831,"eighty":-2.134802,"marketCap":113306310},{"date":"2022-04-01","current":-5.448755,"twenty":-10.226597,"median":-6.495202,"eighty":-2.14736,"marketCap":106771748},{"date":"2022-04-08","current":-5.033379,"twenty":-10.222017,"median":-6.428566,"eighty":-2.159223,"marketCap":98632198},{"date":"2022-04-14","current":-4.862342,"twenty":-10.208726,"median":-6.373813,"eighty":-2.163768,"marketCap":95280618},{"date":"2022-04-22","current":-4.275929,"twenty":-10.203063,"median":-6.301353,"eighty":-2.177454,"marketCap":83789489},{"date":"2022-04-29","current":-3.909829,"twenty":-10.193702,"median":-6.197764,"eighty":-2.180591,"marketCap":76615532},{"date":"2022-05-06","current":-3.738774,"twenty":-10.181527,"median":-6.135392,"eighty":-2.190173,"marketCap":73263603},{"date":"2022-05-13","current":-3.866792,"twenty":-10.178493,"median":-6.056629,"eighty":-2.195537,"marketCap":72805493},{"date":"2022-05-20","current":-3.841353,"twenty":-10.144926,"median":-6.018435,"eighty":-2.196279,"marketCap":72326510},{"date":"2022-05-27","current":-3.815913,"twenty":-10.13141,"median":-5.968469,"eighty":-2.196763,"marketCap":71847526},{"date":"2022-06-03","current":-3.790474,"twenty":-10.127823,"median":-5.931736,"eighty":-2.196884,"marketCap":71368542},{"date":"2022-06-10","current":-3.612398,"twenty":-10.114116,"median":-5.915556,"eighty":-2.204416,"marketCap":68015658},{"date":"2022-06-17","current":-3.332564,"twenty":-10.102352,"median":-5.892055,"eighty":-2.209864,"marketCap":62746839},{"date":"2022-06-24","current":-3.561519,"twenty":-10.092603,"median":-5.866707,"eighty":-2.210876,"marketCap":67057691},{"date":"2022-07-01","current":-3.51064,"twenty":-10.078396,"median":-5.844321,"eighty":-2.213751,"marketCap":66099724},{"date":"2022-07-08","current":-3.637837,"twenty":-10.069671,"median":-5.769394,"eighty":-2.218672,"marketCap":68494641},{"date":"2022-07-15","current":-3.663277,"twenty":-10.049506,"median":-5.706955,"eighty":-2.227654,"marketCap":68973625},{"date":"2022-07-22","current":-3.586959,"twenty":-10.029049,"median":-5.694467,"eighty":-2.227654,"marketCap":67536674},{"date":"2022-07-29","current":-3.53608,"twenty":-10.021472,"median":-5.676784,"eighty":-2.227905,"marketCap":66578707},{"date":"2022-08-05","current":-3.637837,"twenty":-10.020809,"median":-5.669491,"eighty":-2.230011,"marketCap":68494641},{"date":"2022-08-12","current":-4.247333,"twenty":-10.017548,"median":-5.651436,"eighty":-2.234588,"marketCap":84995938},{"date":"2022-08-19","current":-4.799246,"twenty":-10.000269,"median":-5.644515,"eighty":-2.235264,"marketCap":96040608},{"date":"2022-08-26","current":-4.487295,"twenty":-9.980272,"median":-5.639221,"eighty":-2.235844,"marketCap":89797968},{"date":"2022-09-02","current":-3.887389,"twenty":-9.968068,"median":-5.61954,"eighty":-2.238194,"marketCap":77792892},{"date":"2022-09-09","current":-4.223337,"twenty":-9.968068,"median":-5.581198,"eighty":-2.23831,"marketCap":84515735},{"date":"2022-09-16","current":-3.767408,"twenty":-9.91647,"median":-5.544612,"eighty":-2.247098,"marketCap":75391877},{"date":"2022-09-23","current":-3.383468,"twenty":-9.888956,"median":-5.522056,"eighty":-2.249454,"marketCap":67708628},{"date":"2022-09-30","current":-3.383468,"twenty":-9.862585,"median":-5.519637,"eighty":-2.25903,"marketCap":67708628},{"date":"2022-10-07","current":-3.287484,"twenty":-9.861864,"median":-5.494661,"eighty":-2.25903,"marketCap":65787816},{"date":"2022-10-14","current":-3.191499,"twenty":-9.836215,"median":-5.47363,"eighty":-2.259652,"marketCap":63867004},{"date":"2022-10-21","current":-3.071518,"twenty":-9.836215,"median":-5.444709,"eighty":-2.260379,"marketCap":61465989},{"date":"2022-10-28","current":-3.383468,"twenty":-9.816568,"median":-5.347983,"eighty":-2.260379,"marketCap":67708628},{"date":"2022-11-04","current":-3.167502,"twenty":-9.816568,"median":-5.344806,"eighty":-2.260379,"marketCap":63386801},{"date":"2022-11-11","current":-3.335476,"twenty":-9.816568,"median":-5.321915,"eighty":-2.260379,"marketCap":66748222},{"date":"2022-11-18","current":-2.713233,"twenty":-9.805788,"median":-5.269879,"eighty":-2.263422,"marketCap":61472414},{"date":"2022-11-25","current":-2.734431,"twenty":-9.793914,"median":-5.195401,"eighty":-2.266011,"marketCap":61952667},{"date":"2022-12-02","current":-2.776825,"twenty":-9.788025,"median":-5.174979,"eighty":-2.271681,"marketCap":62913174},{"date":"2022-12-09","current":-2.681438,"twenty":-9.784238,"median":-5.14919,"eighty":-2.273037,"marketCap":60752034},{"date":"2022-12-16","current":-2.501262,"twenty":-9.783474,"median":-5.120025,"eighty":-2.274386,"marketCap":56669882},{"date":"2022-12-23","current":-2.119714,"twenty":-9.780257,"median":-5.120025,"eighty":-2.266011,"marketCap":48025324},{"date":"2022-12-30","current":-3.073585,"twenty":-9.779453,"median":-5.093623,"eighty":-2.265364,"marketCap":69636719},{"date":"2023-01-06","current":-3.03119,"twenty":-9.770513,"median":-5.045098,"eighty":-2.26917,"marketCap":68676213},{"date":"2023-01-13","current":-3.03119,"twenty":-9.746555,"median":-5.039238,"eighty":-2.272987,"marketCap":68676213},{"date":"2023-01-20","current":-2.771102,"twenty":-9.727712,"median":-5.005179,"eighty":-2.273393,"marketCap":62783506},{"date":"2023-01-27","current":-2.840416,"twenty":-9.715331,"median":-4.970171,"eighty":-2.274717,"marketCap":64353934},{"date":"2023-02-03","current":-3.62471,"twenty":-9.69636,"median":-4.953595,"eighty":-2.274717,"marketCap":82123304},{"date":"2023-02-10","current":-3.264359,"twenty":-9.624923,"median":-4.920219,"eighty":-2.274717,"marketCap":73958998},{"date":"2023-02-17","current":-3.62471,"twenty":-9.618667,"median":-4.866305,"eighty":-2.276872,"marketCap":82123304},{"date":"2023-02-24","current":-2.882811,"twenty":-9.59888,"median":-4.853817,"eighty":-2.285494,"marketCap":65314440},{"date":"2023-03-03","current":-2.615162,"twenty":-9.582151,"median":-4.815789,"eighty":-2.297312,"marketCap":59250448},{"date":"2023-03-10","current":-2.065748,"twenty":-9.55969,"median":-4.781926,"eighty":-2.297312,"marketCap":46802657},{"date":"2023-03-17","current":-1.777392,"twenty":-9.551256,"median":-4.751254,"eighty":-2.274717,"marketCap":40269515},{"date":"2023-03-24","current":-2.064601,"twenty":-9.546139,"median":-4.703273,"eighty":-2.266658,"marketCap":46776670},{"date":"2023-03-31","current":-2.087312,"twenty":-9.544825,"median":-4.625539,"eighty":-2.260379,"marketCap":47291213},{"date":"2023-04-06","current":-1.835201,"twenty":-9.477575,"median":-4.588917,"eighty":-2.257115,"marketCap":41579262},{"date":"2023-04-14","current":-1.854292,"twenty":-9.391461,"median":-4.500911,"eighty":-2.235264,"marketCap":44022044},{"date":"2023-04-21","current":-2.408171,"twenty":-9.372825,"median":-4.45103,"eighty":-2.227654,"marketCap":57171485},{"date":"2023-04-28","current":-1.798466,"twenty":-9.339055,"median":-4.343318,"eighty":-2.213847,"marketCap":42696705},{"date":"2023-05-05","current":-1.72792,"twenty":-9.292981,"median":-4.275929,"eighty":-2.196642,"marketCap":41021888},{"date":"2023-05-12","current":-1.780029,"twenty":-9.240822,"median":-4.204554,"eighty":-2.175296,"marketCap":42258990},{"date":"2023-05-19","current":-1.663988,"twenty":-9.160106,"median":-4.127352,"eighty":-2.151109,"marketCap":39504099},{"date":"2023-05-26","current":-1.59886,"twenty":-9.027812,"median":-4.080458,"eighty":-2.119714,"marketCap":44182216},{"date":"2023-06-02","current":-1.756865,"twenty":-8.976535,"median":-4.071044,"eighty":-2.094469,"marketCap":48548458},{"date":"2023-06-09","current":-1.698553,"twenty":-8.916846,"median":-4.012381,"eighty":-2.071201,"marketCap":46937107},{"date":"2023-06-16","current":-1.599236,"twenty":-8.860505,"median":-3.982287,"eighty":-2.060797,"marketCap":44192612},{"date":"2023-06-23","current":-1.45026,"twenty":-8.813799,"median":-3.963765,"eighty":-2.01972,"marketCap":40075869},{"date":"2023-06-30","current":-1.542429,"twenty":-8.763841,"median":-3.933678,"eighty":-2.00787,"marketCap":42622843},{"date":"2023-07-07","current":-1.604315,"twenty":-8.740526,"median":-3.886391,"eighty":-1.960912,"marketCap":44332955},{"date":"2023-07-14","current":-1.561804,"twenty":-8.639414,"median":-3.843275,"eighty":-1.927191,"marketCap":43158228},{"date":"2023-07-21","current":-1.627075,"twenty":-8.609679,"median":-3.815913,"eighty":-1.899813,"marketCap":44961902},{"date":"2023-07-28","current":-1.512142,"twenty":-8.570756,"median":-3.790474,"eighty":-1.859059,"marketCap":41785898},{"date":"2023-08-04","current":-1.571587,"twenty":-8.520384,"median":-3.771335,"eighty":-1.835462,"marketCap":43428579},{"date":"2023-08-11","current":-1.38046,"twenty":-8.490003,"median":-3.751893,"eighty":-1.822679,"marketCap":38147046},{"date":"2023-08-18","current":-1.177723,"twenty":-8.477195,"median":-3.739595,"eighty":-1.805771,"marketCap":32544700},{"date":"2023-08-25","current":-0.911773,"twenty":-8.477195,"median":-3.714156,"eighty":-1.796113,"marketCap":27215639},{"date":"2023-09-01","current":-1.034378,"twenty":-8.477195,"median":-3.688716,"eighty":-1.788747,"marketCap":30875284},{"date":"2023-09-08","current":-1.00711,"twenty":-8.47978,"median":-3.671432,"eighty":-1.784421,"marketCap":30061369},{"date":"2023-09-15","current":-1.025223,"twenty":-8.482366,"median":-3.663277,"eighty":-1.779269,"marketCap":30601999},{"date":"2023-09-22","current":-0.855447,"twenty":-8.482366,"median":-3.637837,"eighty":-1.759498,"marketCap":25534341},{"date":"2023-09-29","current":-0.756527,"twenty":-8.482366,"median":-3.612398,"eighty":-1.749089,"marketCap":22581673},{"date":"2023-10-06","current":-0.736425,"twenty":-8.482366,"median":-3.599435,"eighty":-1.731376,"marketCap":21981634},{"date":"2023-10-13","current":-0.655816,"twenty":-8.482366,"median":-3.586959,"eighty":-1.702418,"marketCap":19575536},{"date":"2023-10-20","current":-0.615014,"twenty":-8.484951,"median":-3.591732,"eighty":-1.691713,"marketCap":18357634},{"date":"2023-10-27","current":-0.423324,"twenty":-8.49247,"median":-3.599435,"eighty":-1.68314,"marketCap":12635843},{"date":"2023-11-03","current":-0.498988,"twenty":-8.49247,"median":-3.599435,"eighty":-1.649005,"marketCap":14894366},{"date":"2023-11-10","current":-0.44005,"twenty":-8.49247,"median":-3.599435,"eighty":-1.632997,"marketCap":13135095},{"date":"2023-11-17","current":-0.449421,"twenty":-8.49247,"median":-3.599435,"eighty":-1.621882,"marketCap":14163318},{"date":"2023-11-24","current":-0.529069,"twenty":-8.49247,"median":-3.599435,"eighty":-1.614381,"marketCap":16641750},{"date":"2023-12-01","current":-0.457266,"twenty":-8.49247,"median":-3.599435,"eighty":-1.595199,"marketCap":14383226},{"date":"2023-12-08","current":-0.434592,"twenty":-8.490003,"median":-3.59797,"eighty":-1.577064,"marketCap":13670009},{"date":"2023-12-15","current":-0.421365,"twenty":-8.490003,"median":-3.59797,"eighty":-1.555884,"marketCap":13253965},{"date":"2023-12-22","current":-0.394912,"twenty":-8.490003,"median":-3.59797,"eighty":-1.542198,"marketCap":12421877},{"date":"2023-12-29","current":-0.434592,"twenty":-8.49247,"median":-3.599435,"eighty":-1.511616,"marketCap":13670009},{"date":"2024-01-05","current":-0.434592,"twenty":-8.494936,"median":-3.605917,"eighty":-1.486894,"marketCap":13670009},{"date":"2024-01-12","current":-0.409083,"twenty":-8.494936,"median":-3.605917,"eighty":-1.471591,"marketCap":12867638},{"date":"2024-01-19","current":-0.390377,"twenty":-8.497403,"median":-3.612398,"eighty":-1.402651,"marketCap":12279234},{"date":"2024-01-26","current":-0.430435,"twenty":-8.494936,"median":-3.605917,"eighty":-1.372291,"marketCap":13539252},{"date":"2024-02-02","current":-0.346729,"twenty":-8.494936,"median":-3.605917,"eighty":-1.339755,"marketCap":10906285},{"date":"2024-02-09","current":-0.208321,"twenty":-8.494936,"median":-3.605917,"eighty":-1.314773,"marketCap":6552686},{"date":"2024-02-16","current":-0.206904,"twenty":-8.494936,"median":-3.605917,"eighty":-1.284337,"marketCap":6508110},{"date":"2024-02-23","current":-0.207848,"twenty":-8.494936,"median":-3.605917,"eighty":-1.265892,"marketCap":6537828},{"date":"2024-03-01","current":-0.203124,"twenty":-8.49247,"median":-3.599435,"eighty":-1.254668,"marketCap":6389241},{"date":"2024-03-08","current":-0.200763,"twenty":-8.49247,"median":-3.599435,"eighty":-1.240197,"marketCap":6314947},{"date":"2024-03-15","current":-0.196511,"twenty":-8.49247,"median":-3.599435,"eighty":-1.229176,"marketCap":6181219},{"date":"2024-03-22","current":-0.142659,"twenty":-8.49247,"median":-3.599435,"eighty":-1.224346,"marketCap":4487327},{"date":"2024-03-28","current":-0.128016,"twenty":-8.49247,"median":-3.599435,"eighty":-1.215365,"marketCap":4026707},{"date":"2024-04-05","current":-0.185098,"twenty":-8.494936,"median":-3.605917,"eighty":-1.202437,"marketCap":5712218},{"date":"2024-04-12","current":-0.172098,"twenty":-8.494936,"median":-3.605917,"eighty":-1.194249,"marketCap":5311025},{"date":"2024-04-19","current":-0.137394,"twenty":-8.494936,"median":-3.605917,"eighty":-1.157359,"marketCap":4240032},{"date":"2024-04-26","current":-0.13124,"twenty":-8.49247,"median":-3.599435,"eighty":-1.104089,"marketCap":4050134},{"date":"2024-05-03","current":-0.160494,"twenty":-8.49247,"median":-3.599435,"eighty":-1.06657,"marketCap":4952927},{"date":"2024-05-10","current":-0.165255,"twenty":-8.49247,"median":-3.599435,"eighty":-1.034736,"marketCap":5099836},{"date":"2024-05-17","current":-0.183839,"twenty":-8.49247,"median":-3.599435,"eighty":-1.01129,"marketCap":5078849},{"date":"2024-05-24","current":-0.167634,"twenty":-8.49247,"median":-3.599435,"eighty":-0.977772,"marketCap":4631154},{"date":"2024-05-31","current":-0.183563,"twenty":-8.49247,"median":-3.599435,"eighty":-0.959893,"marketCap":5071218},{"date":"2024-06-07","current":-0.207457,"twenty":-8.49247,"median":-3.599435,"eighty":-0.925746,"marketCap":5731315},{"date":"2024-06-14","current":-0.183563,"twenty":-8.494936,"median":-3.605917,"eighty":-0.896806,"marketCap":5071218},{"date":"2024-06-21","current":-0.155498,"twenty":-8.497403,"median":-3.612398,"eighty":-0.856995,"marketCap":4295867},{"date":"2024-06-28","current":-0.14943,"twenty":-8.500834,"median":-3.612398,"eighty":-0.789805,"marketCap":4128223},{"date":"2024-07-05","current":-0.144878,"twenty":-8.500834,"median":-3.612398,"eighty":-0.75175,"marketCap":4002490},{"date":"2024-07-12","current":-0.139569,"twenty":-8.500834,"median":-3.612398,"eighty":-0.725518,"marketCap":3855802},{"date":"2024-07-15","current":-0.145637,"twenty":-8.500834,"median":-3.612398,"eighty":-0.722479,"marketCap":4023446},{"date":"2024-08-02","current":-0.127432,"twenty":-8.515816,"median":-3.637837,"eighty":-0.700599,"marketCap":3520515},{"date":"2024-08-09","current":-0.107711,"twenty":-8.515816,"median":-3.637837,"eighty":-0.696618,"marketCap":2975673},{"date":"2024-08-16","current":-0.06455,"twenty":-8.515816,"median":-3.637837,"eighty":-0.6831,"marketCap":1687473},{"date":"2024-08-23","current":-0.096384,"twenty":-8.515816,"median":-3.637837,"eighty":-0.664031,"marketCap":2519695},{"date":"2024-08-30","current":-0.092434,"twenty":-8.515816,"median":-3.637837,"eighty":-0.649115,"marketCap":2416417},{"date":"2024-09-06","current":-0.068688,"twenty":-8.515816,"median":-3.637837,"eighty":-0.635185,"marketCap":1795669},{"date":"2024-09-13","current":-0.05919,"twenty":-8.515816,"median":-3.637837,"eighty":-0.628095,"marketCap":1547370},{"date":"2024-09-20","current":-0.053684,"twenty":-8.515816,"median":-3.637837,"eighty":-0.596902,"marketCap":1403429},{"date":"2024-09-27","current":-0.048109,"twenty":-8.515816,"median":-3.637837,"eighty":-0.58349,"marketCap":1257688},{"date":"2024-10-04","current":-0.045425,"twenty":-8.515816,"median":-3.637837,"eighty":-0.530036,"marketCap":1187517},{"date":"2024-10-11","current":-0.046774,"twenty":-8.515816,"median":-3.637837,"eighty":-0.525687,"marketCap":1222782},{"date":"2024-10-18","current":-0.046788,"twenty":-8.515816,"median":-3.637837,"eighty":-0.498907,"marketCap":1223142},{"date":"2024-10-25","current":-0.294576,"twenty":-8.515816,"median":-3.637837,"eighty":-0.489223,"marketCap":7700869},{"date":"2024-10-31","current":-0.278058,"twenty":-8.515816,"median":-3.637837,"eighty":-0.475673,"marketCap":7269044},{"date":"2024-11-08","current":-0.232632,"twenty":-8.51619,"median":-3.637837,"eighty":-0.467657,"marketCap":6081527},{"date":"2024-11-15","current":-0.259868,"twenty":-8.51619,"median":-3.637837,"eighty":-0.459349,"marketCap":5901600},{"date":"2024-11-22","current":-0.18064,"twenty":-8.51619,"median":-3.637837,"eighty":-0.455934,"marketCap":4102332},{"date":"2024-11-29","current":-0.408358,"twenty":-8.51619,"median":-3.637837,"eighty":-0.454848,"marketCap":9273794},{"date":"2024-12-06","current":-0.404612,"twenty":-8.51619,"median":-3.637837,"eighty":-0.447819,"marketCap":9188713},{"date":"2024-12-13","current":-0.397119,"twenty":-8.51619,"median":-3.637837,"eighty":-0.445625,"marketCap":9018552},{"date":"2024-12-20","current":-0.337176,"twenty":-8.51619,"median":-3.637837,"eighty":-0.443656,"marketCap":7657261},{"date":"2024-12-27","current":-0.33343,"twenty":-8.51619,"median":-3.637837,"eighty":-0.443656,"marketCap":7572180},{"date":"2025-01-03","current":-0.337514,"twenty":-8.51619,"median":-3.637837,"eighty":-0.44005,"marketCap":7664918},{"date":"2025-01-10","current":-0.288885,"twenty":-8.516564,"median":-3.637837,"eighty":-0.434592,"marketCap":6560571},{"date":"2025-01-17","current":-0.262248,"twenty":-8.516564,"median":-3.637837,"eighty":-0.430359,"marketCap":5955647},{"date":"2025-01-24","current":-0.264122,"twenty":-8.516564,"median":-3.637837,"eighty":-0.419173,"marketCap":5998187},{"date":"2025-01-31","current":-0.228531,"twenty":-8.516564,"median":-3.62471,"eighty":-0.411879,"marketCap":5189921},{"date":"2025-02-07","current":-0.18732,"twenty":-8.516564,"median":-3.621481,"eighty":-0.408358,"marketCap":4254034},{"date":"2025-02-14","current":-0.176456,"twenty":-8.516564,"median":-3.612398,"eighty":-0.404058,"marketCap":4007300},{"date":"2025-02-21","current":-0.14817,"twenty":-8.49247,"median":-3.596505,"eighty":-0.399258,"marketCap":3364940},{"date":"2025-02-28","current":-0.14049,"twenty":-8.420685,"median":-3.561119,"eighty":-0.394912,"marketCap":3190525},{"date":"2025-03-07","current":-0.125505,"twenty":-8.382425,"median":-3.53608,"eighty":-0.389926,"marketCap":2850202},{"date":"2025-03-14","current":-0.134908,"twenty":-8.382425,"median":-3.51064,"eighty":-0.364966,"marketCap":3063755},{"date":"2025-03-21","current":-0.14064,"twenty":-8.370864,"median":-3.479453,"eighty":-0.343245,"marketCap":3193928},{"date":"2025-03-28","current":-0.128127,"twenty":-8.370864,"median":-3.453207,"eighty":-0.330126,"marketCap":2909759},{"date":"2025-04-04","current":-0.171687,"twenty":-8.370864,"median":-3.421602,"eighty":-0.317305,"marketCap":3672082},{"date":"2025-04-11","current":-0.299253,"twenty":-8.367064,"median":-3.383468,"eighty":-0.297933,"marketCap":6400504},{"date":"2025-04-17","current":-0.288525,"twenty":-8.367064,"median":-3.371724,"eighty":-0.294188,"marketCap":6171052},{"date":"2025-04-25","current":-0.300947,"twenty":-8.370864,"median":-3.353576,"eighty":-0.288026,"marketCap":6436733},{"date":"2025-05-02","current":-0.310884,"twenty":-8.370864,"median":-3.332564,"eighty":-0.288026,"marketCap":6649279},{"date":"2025-05-09","current":-0.323984,"twenty":-8.291247,"median":-3.292403,"eighty":-0.288026,"marketCap":6929452},{"date":"2025-05-16","current":-0.295057,"twenty":-8.281861,"median":-3.278689,"eighty":-0.285135,"marketCap":5719394},{"date":"2025-05-23","current":-0.3287,"twenty":-8.281861,"median":-3.263487,"eighty":-0.285135,"marketCap":6371521},{"date":"2025-05-30","current":-0.414924,"twenty":-8.281861,"median":-3.246845,"eighty":-0.285135,"marketCap":8042898},{"date":"2025-06-06","current":-0.339914,"twenty":-8.281861,"median":-3.196134,"eighty":-0.285135,"marketCap":6588896},{"date":"2025-06-13","current":-0.390128,"twenty":-8.281861,"median":-3.167502,"eighty":-0.285135,"marketCap":7562256},{"date":"2025-06-20","current":-0.45194,"twenty":-8.280352,"median":-3.11951,"eighty":-0.284282,"marketCap":8760414},{"date":"2025-06-27","current":-0.350179,"twenty":-8.208524,"median":-3.095514,"eighty":-0.284282,"marketCap":6787870},{"date":"2025-07-03","current":-0.389537,"twenty":-8.161542,"median":-3.071518,"eighty":-0.284282,"marketCap":7550781},{"date":"2025-07-11","current":-0.435329,"twenty":-8.107477,"median":-3.022063,"eighty":-0.284282,"marketCap":8438425},{"date":"2025-07-18","current":-0.424255,"twenty":-8.0232,"median":-2.936322,"eighty":-0.284282,"marketCap":8223766},{"date":"2025-07-25","current":-0.488181,"twenty":-7.893378,"median":-2.861613,"eighty":-0.284282,"marketCap":9462911},{"date":"2025-08-01","current":-0.394991,"twenty":-7.832142,"median":-2.819219,"eighty":-0.284282,"marketCap":7656506},{"date":"2025-08-08","current":-0.378576,"twenty":-7.672084,"median":-2.776825,"eighty":-0.284282,"marketCap":7338313},{"date":"2025-08-15","current":-0.369342,"twenty":-7.547318,"median":-2.755628,"eighty":-0.284282,"marketCap":7159330},{"date":"2025-08-22","current":-0.274014,"twenty":-7.45155,"median":-2.692036,"eighty":-0.28207,"marketCap":4812523},{"date":"2025-08-29","current":-0.332894,"twenty":-7.38144,"median":-2.653034,"eighty":-0.28207,"marketCap":5846647},{"date":"2025-09-05","current":-0.296689,"twenty":-7.330145,"median":-2.607248,"eighty":-0.28173,"marketCap":5210778}],"updateTime":1757365665180},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNPX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561890264","title":"Genprex Inc. Faces Potential Nasdaq Delisting Due to Non-Compliance with Stockholders' Equity Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2561890264","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561890264?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:16","pubTimestamp":1755721014,"startTime":"0","endTime":"0","summary":"Genprex Inc. has announced a regulatory issue concerning its listing on the Nasdaq Stock Market. On August 19, 2025, the company received a letter from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market. Genprex reported stockholders' equity of $1,391,195 for the period ending June 30, 2025, falling short of the required $2.5 million threshold. Additionally, the company did not meet alternative compliance standards related to market value or net income. This non-compliance serves as a basis for potential delisting from Nasdaq. Genprex has disclosed this issue via a Form 8-K filing and is considering actions to address the deficiency and maintain its listing status. The company is evaluating its options and potential responses to ensure compliance.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL1gBSP4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2560887631","title":"Genprex Inc. Receives Notice of Allowance for Patents on Reqorsa® Gene Therapy with PD-L1 and PD-1 Antibodies to Combat Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2560887631","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560887631?lang=en_us&edition=fundamental","pubTime":"2025-08-18 21:29","pubTimestamp":1755523759,"startTime":"0","endTime":"0","summary":"Genprex Inc. Receives Notice of Allowance for Patents on Reqorsa Gene Therapy with PD-L1 and PD-1 Antibodies to Combat Cancers. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Newswire  on August 18, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nNDLbNZ6YZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2559294684","title":"Genprex Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2559294684","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559294684?lang=en_us&edition=fundamental","pubTime":"2025-08-16 04:11","pubTimestamp":1755288706,"startTime":"0","endTime":"0","summary":"Genprex Inc. held its 2025 Annual Meeting on August 15, 2025. During the meeting, stockholders voted on several proposals. The election of a director was approved. The appointment of the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was also approved. Additionally, the amended and restated 2018 Equity Incentive Plan received approval. No other business was presented at the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 15, 2025, and is solely responsible for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDL16bY8s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2559962714","title":"Genprex Q2 EPS $(0.17) Beats $(0.42) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559962714","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559962714?lang=en_us&edition=fundamental","pubTime":"2025-08-15 05:21","pubTimestamp":1755206519,"startTime":"0","endTime":"0","summary":"Genprex (NASDAQ:GNPX) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.42) by 59.52 percent. This is a 94.33 percent increase over losses of $(3.00) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47142457/genprex-q2-eps-0-17-beats-0-42-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Genprex Q2 EPS $(0.17) Beats $(0.42) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX"],"gpt_icon":0},{"id":"2556384275","title":"Genprex Inc. Reports Significant Deviation from Forecast with Lower Sales and Increased Net Loss in Latest Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2556384275","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556384275?lang=en_us&edition=fundamental","pubTime":"2025-08-04 21:14","pubTimestamp":1754313263,"startTime":"0","endTime":"0","summary":"Genprex Inc. has released its latest financial results, highlighting a significant variation in its performance metrics. The company reported a notable change in its financial status compared to the previous period, with a focus on its clinical development, manufacturing, and commercialization efforts. Although specific figures for sales, revenues, and net income/profit/loss were not detailed, the company emphasized its ongoing commitment to advancing its product candidates for cancer and diabetes treatments. Additionally, Genprex provided an outlook on its future growth and financial status, underscoring its ability to maintain compliance with the continued listing requirements of The Nasdaq Capital Market. The company remains focused on obtaining the necessary capital to meet its long-term liquidity needs and expanding its strategic partnerships, including those with third-party vendors and manufacturers.Disclaimer: This news brief was created by Public Technologies  using generative","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL73dQq2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX"],"gpt_icon":0},{"id":"2556384464","title":"BRIEF-Genprex Issues Stockholder Letter And Provides 2025 Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2556384464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556384464?lang=en_us&edition=fundamental","pubTime":"2025-08-04 21:10","pubTimestamp":1754313023,"startTime":"0","endTime":"0","summary":"BRIEF-Genprex Issues Stockholder Letter And Provides 2025 Corporate UpdateAug 4 (Reuters) - Genprex Inc GNPX.O:GENPREX ISSUES STOCKHOLDER LETTER AND PROVIDES 2025 CORPORATE UPDATESource text: ID:nPn71mktsaFurther company coverage: GNPX.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nTUA47FRLZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2556381182","title":"Genprex Inc. Announces New Progress in Lung Cancer Clinical Trials and Outlines Key Milestones for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2556381182","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556381182?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:30","pubTimestamp":1754310632,"startTime":"0","endTime":"0","summary":"Genprex Inc., a clinical-stage gene therapy company, has announced significant progress in its clinical development program for 2025. The company is currently conducting patient treatment in two lung cancer clinical trials. These trials are part of Genprex's larger focus on developing therapies for cancer and diabetes. The results of these clinical studies have not been presented yet, but the company has outlined key milestones for the second half of 2025 and beyond. Further details are available in a stockholder letter and corporate update issued by Genprex, which is accessible on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL14pPhz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Genprex Inc. Announces New Progress in Lung Cancer Clinical Trials and Outlines Key Milestones for 2025","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2545280713","title":"Genprex Inc. Announces Promising Preclinical Results for Diabetes Gene Therapy GPX-002 at 2025 ADA Scientific Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=2545280713","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545280713?lang=en_us&edition=fundamental","pubTime":"2025-06-24 21:25","pubTimestamp":1750771527,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Newswire  on June 24, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDLc3YtwY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2545241283","title":"Genprex Announces Promising Preclinical Results for Novel Diabetes Gene Therapy Using Non-Viral Lipid Nanoparticle Delivery System at 2025 ADA Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2545241283","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545241283?lang=en_us&edition=fundamental","pubTime":"2025-06-23 21:01","pubTimestamp":1750683698,"startTime":"0","endTime":"0","summary":"Genprex Announces Promising Preclinical Results for Novel Diabetes Gene Therapy Using Non-Viral Lipid Nanoparticle Delivery System at 2025 ADA Conference. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Newswire  on June 23, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDL4n8Yn2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2542558309","title":"Genprex Files for Resale of 15 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2542558309","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542558309?lang=en_us&edition=fundamental","pubTime":"2025-06-12 05:42","pubTimestamp":1749678172,"startTime":"0","endTime":"0","summary":"Genprex (GNPX) filed a registration statement Wednesday for the sale of up to 15 million common shares from time to time on behalf of a selling shareholder, Lincoln Park Capital Fund.The company said it will not receive any of the proceeds from the sale of the shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2542653070","title":"Genprex Inc. Enters $12.5 Million Share Purchase Agreement with Lincoln Park Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2542653070","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542653070?lang=en_us&edition=fundamental","pubTime":"2025-06-12 05:24","pubTimestamp":1749677091,"startTime":"0","endTime":"0","summary":"On June 11, 2025, Genprex, Inc. entered into a purchase agreement with Lincoln Park Capital Fund, LLC. Under this agreement, Lincoln Park committed to purchase up to $12.5 million in shares of Genprex's common stock. The document does not specify the total number of shares or the price per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL8SxNN7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2542216386","title":"Genprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge","url":"https://stock-news.laohu8.com/highlight/detail?id=2542216386","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542216386?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:01","pubTimestamp":1749466873,"startTime":"0","endTime":"0","summary":"Genprex Inc. announced that it has successfully regained compliance with Nasdaq's minimum stockholders' equity requirement, as confirmed in a letter from Nasdaq's Listing Qualifications Department on June 6, 2025. Previously, the company had been notified in November 2024 that it was not meeting the minimum stockholders' equity of $2.5 million. However, based on Genprex's recent quarterly report, Nasdaq has confirmed that the company now meets the necessary requirements, resolving the prior issue. Additionally, Genprex is working to address another compliance matter regarding the minimum bid price of its common stock, which remains below the required $1.00 per share. The company has until August 6, 2025, to rectify this situation and is considering strategies such as a reverse stock split to meet Nasdaq's standards.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL5Yc8PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2540708869","title":"Genprex Inc. Announces Phase 1/2 Clinical Trial of Quaratusugene Ozeplasmid Gene Therapy for Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2540708869","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540708869?lang=en_us&edition=fundamental","pubTime":"2025-06-03 22:51","pubTimestamp":1748962304,"startTime":"0","endTime":"0","summary":"Genprex, Inc., based in Austin, TX, has announced the initiation of a Phase 1/2 clinical trial for Quaratusugene Ozeplasmid gene therapy combined with Atezolizumab maintenance therapy in patients with Extensive Stage Small Cell Lung Cancer . This study aims to evaluate the efficacy and safety of the TUSC2 gene encapsulated in lipid-based nanoparticles. The trial will include patients who have shown a complete response, partial response, or stable disease after receiving three to four cycles of standard treatment, which includes atezolizumab, carboplatin, and etoposide. The study's design and methodology include a futility analysis after the 25th patient reaches 18 weeks of follow-up, with patient eligibility criteria focusing on those with an ECOG Performance Status of 0 to 1. Further details are available on Genprex's official website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and tim","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDLcDKHj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2540775929","title":"Genprex Inc. to Participate in BIO International Convention in Boston","url":"https://stock-news.laohu8.com/highlight/detail?id=2540775929","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540775929?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:00","pubTimestamp":1748948437,"startTime":"0","endTime":"0","summary":"Genprex Inc., a clinical-stage gene therapy company, will participate in the BIO 2025 International Convention from June 16-19, 2025, in Boston. The company, which focuses on developing therapies for cancer and diabetes, will have Senior Vice President Thomas Gallagher available for one-on-one meetings to discuss their gene therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Newswire  on June 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL4lj8Rv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2538642015","title":"Genprex Inc. Announces Promising Preclinical Results for Novel Diabetes Gene Therapy at ASGCT Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2538642015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538642015?lang=en_us&edition=fundamental","pubTime":"2025-05-28 19:01","pubTimestamp":1748430061,"startTime":"0","endTime":"0","summary":"Genprex Inc., a clinical-stage gene therapy company, recently announced positive preclinical results for its diabetes gene therapy, GPX-002. Presented at the American Society of Gene and Cell Therapy's 28th Annual Meeting, the study highlights the potential of GPX-002 in treating both Type 1 and Type 2 diabetes. The therapy utilizes intraductal infusion of recombinant adeno-associated virus to deliver Pdx1 and MafA genes, converting alpha cells into insulin-secreting beta-like cells. In mouse models, this approach successfully reversed diabetes without the need for immunosuppression. However, in non-human primate models, an anti-viral immune response was observed, which initially affected glucose tolerance improvements. Researchers found that administering a multi-agent immunosuppression regimen could largely prevent this immune response, sustaining therapeutic effects. Ongoing studies aim to gather further data on the viral efficacy of GPX-002 after six months of immunosuppression in ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL2NJCy4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2535780754","title":"Genprex Q1 EPS $(0.26) Beats $(0.41) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535780754","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535780754?lang=en_us&edition=fundamental","pubTime":"2025-05-13 05:35","pubTimestamp":1747085744,"startTime":"0","endTime":"0","summary":"Genprex (NASDAQ:GNPX) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.41) by 36.59 percent. This is a 92.95 percent increase over losses of $(3.69) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45362999/genprex-q1-eps-0-26-beats-0-41-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX"],"gpt_icon":0},{"id":"2534679234","title":"Genprex Inc  expected to post a loss of 41 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534679234","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534679234?lang=en_us&edition=fundamental","pubTime":"2025-05-10 07:57","pubTimestamp":1746835025,"startTime":"0","endTime":"0","summary":"Genprex Inc  expected to post a loss of41cents a share - Earnings Preview Genprex Inc GNPX.OQ GNPX.O is expected to report results on May 13 (estimated) for the period ending March 31 2025LSEG's mean ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH3W0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX"],"gpt_icon":0},{"id":"2531032828","title":"BRIEF-Genprex Collaborators Report Positive Preclinical Data On The Use Of Reqorsa Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2531032828","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531032828?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:42","pubTimestamp":1746016927,"startTime":"0","endTime":"0","summary":"BRIEF-Genprex Collaborators Report Positive Preclinical Data On The Use Of Reqorsa Gene Therapy April 30 (Reuters) - Genprex Inc GNPX.O:GENPREX COLLABORATORS REPORT POSITIVE PRECLINICAL DATA ON THE US","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA24LBHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}